Skip to main content

Proposed bulletins

Public comments

The bulletins below are in the process of development by the Division of Financial Regulation (DFR). The division is asking for public review and comment as part of that process. All comments received will be given full consideration and a final report discussing our general response as applied to the bulletin’s final version will be released.

Comments can be submitted in the following ways (Please include the bulletin number or name in the subject line of your comment):

Email:
dfr.bulletin@oregon.gov

Mail:
Department of Consumer and Business Services
Division of Financial Regulation
350 Winter St. NE
P.O. Box 14480
Salem, OR 97309-0405

Proposed bulletins

Guidance on the Use of Step-down Limits in Auto Policies

Summary:
The Division of Financial Regulation (DFR) is preparing to issue a bulletin that provides guidance on the use of step-down limits in auto policies and outlines disclosures necessary to inform consumers of the nature and extent of coverage. The division requests feedback from all stakeholders on the attached guidance. Please submit all comments to DFR.Bulletin@oregon.gov. Please be aware that comments received by DFR are part of the public record and may be published on the division’s website.

Draft Bulletin: Guidance on Step-Down Limits

Last day for public comment: Thursday, March 19, 2020 at 5 p.m.

Guidance on Exclusionary Language Regarding Controlled Substances

Summary:
Exclusionary language relating to controlled substances must clearly describe the risks being excluded. Exclusions relating to the use or other activity associated with controlled substances must be limited to losses that are causally related to the described activity. The division requests feedback from all stakeholders on the attached guidance. Please submit all comments to Raven.V.Collins@oregon.gov.

Draft Bulletin: Guidance on Exclusionary Language Regarding Controlled Substances

Last day for public comment: Monday, February 10, 2020

Guidance on Intentional Acts Exclusions

Summary:
Recently, DFR has received numerous policy filings applying new, expansive language to intentional acts of exclusions. Intentional acts exclusions may not encompass losses due to negligence. Policy language must apply intentional acts exclusions to “the insured.” The division requests feedback from all stakeholders on the attached guidance. Please submit all comments to Raven.V.Collins@oregon.gov.

Draft Bulletin: Guidance on Intentional Acts Exclusions

Last day for public comment: Monday, February 10, 2020

Guidance for Health Benefit Plan External Review Requests

Summary:
The Division of Financial Regulation is preparing to issue a bulletin to provide operational guidance and clarification on the external review process for individual and group health benefit plans in the state of Oregon, and clarifies the Division of Financial Regulation’s (division) expectations of health insurers. The division requests feedback from all stakeholders on the attached guidance. Please submit all comments to DFR.Bulletins@oregon.gov.

Draft Bulletin: Guidance for Health Benefit Plan External Review Requests

Last day for public comment: Monday, January 6, 2020

Co-sponsoring events with intermediaries and other activities prohibited by the title company marketing rules under OAR 836-080-0305 to 836-080-0370

Summary:
The Division of Financial Regulation is preparing to issue a bulletin to remind title companies that co-sponsorship of events with intermediaries and making donations to an intermediary’s charitable foundation violate the title company marketing rules under OAR 836-080-0305 to 836-080-0370 (Rules). The division requests feedback from all stakeholders on the attached guidance. Please submit all comments to DFR.Bulletins@oregon.gov.

Draft Bulletin: Co-sponsoring events

Last day for public comment: Friday , November 15, 2019

Implementation of 60-day advance notice of specified prescription drug price increases as required by HB 2658 (2019)

Summary:
The Division of Financial Regulation is preparing to issue a bulletin regarding the form and manner of reports required from pharmaceutical manufacturers at least 60 days in advance of specified increases in the prices of prescription drugs. The division requests feedback from all stakeholders on the attached guidance. Please submit all comments to DFR.Rules@oregon.gov.

Draft Bulletin: Implementation of 60-day advance notice (HB 2658)

Last day for public comment: Monday, November 18, 2019

​​​​​​​​​​​​​​​​​​​​​​​​​​

Your browser is out-of-date! It has known security flaws and may not display all features of this and other websites. Learn how

×